BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24045550)

  • 1. Hidden mastocytosis in acute myeloid leukemia with t(8;21)(q22;q22).
    Johnson RC; Savage NM; Chiang T; Gotlib JR; Cherry AM; Arber DA; George TI
    Am J Clin Pathol; 2013 Oct; 140(4):525-35. PubMed ID: 24045550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic mastocytosis associated with t(8;21) acute myeloid leukemia in a child: detection of the D816A mutation of KIT.
    Yabe M; Masukawa A; Kato S; Yabe H; Nakamura N; Matsushita H
    Pediatr Blood Cancer; 2012 Dec; 59(7):1313-6. PubMed ID: 22847983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
    Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients.
    Won D; Chi HS; Shim H; Jang S; Park CJ; Lee JH
    Leuk Res; 2013 Aug; 37(8):883-8. PubMed ID: 23683787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes.
    Xie W; Wang SA; Yin CC; Xu J; Li S; Bueso-Ramos CE; Medeiros LJ; Tang G
    Exp Mol Pathol; 2019 Jun; 108():131-136. PubMed ID: 31004601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone.
    Pullarkat V; Bedell V; Kim Y; Bhatia R; Nakamura R; Forman S; Sun J; Senitzer D; Slovak ML
    Leuk Res; 2007 Feb; 31(2):261-5. PubMed ID: 16876862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia.
    Mahadeo KM; Wolgast L; McMahon C; Cole PD
    Pediatr Blood Cancer; 2011 Oct; 57(4):684-7. PubMed ID: 21671435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
    Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
    Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.
    Ustun C; Corless CL; Savage N; Fiskus W; Manaloor E; Heinrich MC; Lewis G; Ramalingam P; Kepten I; Jillella A; Bhalla K
    Leuk Res; 2009 May; 33(5):735-41. PubMed ID: 18986703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1.
    Pullarkat ST; Pullarkat V; Lagoo A; Brynes R; Weiss LM; Bedell V; Chen W; Huang Q; Gaal K; Weisenburger DD; Kim YS
    Leuk Res; 2013 Nov; 37(11):1572-5. PubMed ID: 24035334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia.
    Kristensen T; Preiss B; Broesby-Olsen S; Vestergaard H; Friis L; Møller MB
    Leuk Lymphoma; 2012 Jul; 53(7):1338-44. PubMed ID: 22145956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic mastocytosis with associated acute myeloid leukemia with t (8; 21) (q22; q22).
    Gadage VS; Kadam Amare PS; Galani KS; Mittal N
    Indian J Pathol Microbiol; 2012; 55(3):409-12. PubMed ID: 23032848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia.
    Wakita S; Yamaguchi H; Miyake K; Mitamura Y; Kosaka F; Dan K; Inokuchi K
    Leukemia; 2011 Sep; 25(9):1423-32. PubMed ID: 21606963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
    Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
    J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Childhood systemic mastocytosis associated with t (8; 21) (q22; q22) acute myeloid leukemia'.
    Rabade N; Tembhare P; Patkar N; Amare P; Arora B; Subramanian PG; Gujral S
    Indian J Pathol Microbiol; 2016; 59(3):407-9. PubMed ID: 27510692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
    Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M
    Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic mastocytosis with an associated t(8;21)(q22;q22) acute myeloid leukemia.
    Wimmer J; Hurstel R
    Blood; 2021 May; 137(18):2564. PubMed ID: 33956065
    [No Abstract]   [Full Text] [Related]  

  • 19. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).
    Sotlar K; Colak S; Bache A; Berezowska S; Krokowski M; Bültmann B; Valent P; Horny HP
    J Pathol; 2010 Apr; 220(5):586-95. PubMed ID: 20112369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V.
    Fritsche-Polanz R; Fritz M; Huber A; Sotlar K; Sperr WR; Mannhalter C; Födinger M; Valent P
    Mol Oncol; 2010 Aug; 4(4):335-46. PubMed ID: 20471335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.